======= COMMD2 ======= == Gene Information == * **Official Symbol**: COMMD2 * **Official Name**: COMM domain containing 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51122|51122]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q86X83|Q86X83]] * **Interactions**: [[https://thebiogrid.org/search.php?search=COMMD2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20COMMD2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616699|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes (PubMed:21778237). May down-regulate activation of NF-kappa-B (PubMed:15799966). {ECO:0000269|PubMed:15799966, ECO:0000305|PubMed:21778237}. |HCaRG| No GO term information is available for this gene. \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-2.47| |[[:results:exp470|Chloroquine 32μM R08 exp470]]|-2.4| |[[:results:exp79|Q15 2.7μM R02 exp79]]|-2.36| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.22| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-2.03| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.89| |[[:results:exp85|UM0129480 7μM R02 exp85]]|-1.89| |[[:results:exp146|Quinacrine 2.5μM R03 exp146]]|-1.75| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|1.71| ^Gene^Correlation^ |[[:human genes:c:commd5|COMMD5]]|0.594| |[[:human genes:v:vps29|VPS29]]|0.518| |[[:human genes:a:arpc2|ARPC2]]|0.518| |[[:human genes:c:commd7|COMMD7]]|0.515| |[[:human genes:c:commd3|COMMD3]]|0.51| |[[:human genes:c:commd9|COMMD9]]|0.503| |[[:human genes:a:arpc4|ARPC4]]|0.482| |[[:human genes:a:actr3|ACTR3]]|0.479| |[[:human genes:c:commd10|COMMD10]]|0.474| |[[:human genes:c:ccdc22|CCDC22]]|0.472| |[[:human genes:c:commd8|COMMD8]]|0.464| |[[:human genes:l:lzic|LZIC]]|0.452| |[[:human genes:k:kiaa0196|KIAA0196]]|0.436| |[[:human genes:k:kiaa1033|KIAA1033]]|0.422| |[[:human genes:c:ccdc53|CCDC53]]|0.421| |[[:human genes:a:acsl4|ACSL4]]|0.412| |[[:human genes:c:c16orf62|C16orf62]]|0.409| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10111 * **Expression level (log2 read counts)**: 5.65 {{:chemogenomics:nalm6 dist.png?nolink |}}